Sitron Medical Hui acquires 60% of Ewell HK: it is expected to hit the Southeast Asian smart medical market
On May 10th, Sitron Medical Hui announced that its wholly-owned subsidiary, Sitron Hong Kong, invested 6 million Hong Kong dollars, acquired 30% equity of EwellHK, and simultaneously invested 14 million Hong Kong dollars in cash to subscribe for the new issue of EwellHK. 3 million shares. Upon completion of the transaction, Ewell HK issued a total of 7 million shares and Sitron Hong Kong holds a 60% equity interest in Ewell HK.
It is understood that Ewell HK was established in 2009. It is an integrator specializing in providing comprehensive medical solutions. It provides one-stop medical solutions in Hong Kong, Macau and Southeast Asia. Services include medical software, Internet of Things and wireless network architecture. It is the partner of the company's smart medical business in Hong Kong, Macau and Southeast Asia. Its professional team has many years of experience in implementing the overall solution for information construction in medical institutions.
Before and after this investment, the shareholding structure of Ewell HK changed as follows: (Source: Sitron Medical News Announcement)
As of March 31, 2017, the unaudited major financial data of Ewell HK are as follows: total assets of HK$3,345,578, net assets of HK$220,789, and operating income of HK$5,588,494 in FY2017 The net profit was HK$2,563,022.
In the first quarter of the company, the revenue growth was obvious
In the first quarter of 2017, Sicre Medical Hui realized a net profit attributable to owners of the parent company of RMB 34.052 million, an increase of 25.55% over the same period of the previous year; and an operating income of RMB 213 million. The year-on-year decrease was 2.42%; the basic earnings per share was 0.08 yuan.
The company's revenue growth rate fell slightly less than expected, the net profit growth rate was in line with expectations, the smart medical business continued to exert strength, and the company's overall gross profit level increased year-on-year. The lower total revenue was lower than expected due to the slowdown in RFID orders, and the smart medical business was also related to the VAT refund of more than 10 million yuan.
The company's new orders received in the first quarter totaled 207,599,500 yuan, an increase of 11.53% year-on-year, of which business intelligence business orders were 16,835,700 yuan, and smart medical products orders were 39,427,800 yuan.
In addition, following the establishment of the Watson Joint Consultation Center of Zhejiang Provincial Hospital of Traditional Chinese Medicine at the end of 2016 and the provision of Watson Cancer Consultation Service, in the first quarter of 2017, Sitron Medical Hui has jointly invested in the Third Central Hospital of Tianjin and Panyu District Cancer Research. The North Jiangsu People's Hospital established the Watson Cancer Joint Conference Center, and the number of hospitals expanded to four. The Watson tumor-assisted treatment model and the multi-disciplinary consultation platform were recognized by the market and progressed smoothly.
Bedsore Cushion,Bed Sore Pads,Anti Bedsore Cushion,Bedsore Cushions
XIAMEN DORRELLA HEALTH TECHNOLOGY CO.,LTD , https://www.dinglimed.com